Closol 0,5 mg/g creme Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

closol 0,5 mg/g creme

2care4 generics aps - clobetasolpropionat - creme - 0,5 mg/g

Dermovat 0,5 mg/ml kutanopløsning Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

dermovat 0,5 mg/ml kutanopløsning

nordic prime aps - clobetasolpropionat - kutanopløsning - 0,5 mg/ml

Infilea 500 mikrogram/g shampoo Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

infilea 500 mikrogram/g shampoo

egis pharmaceuticals plc - clobetasolpropionat - shampoo - 500 mikrogram/g

Mometason "Orifarm" 50 mikrogram/dosis næsespray, suspension Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

mometason "orifarm" 50 mikrogram/dosis næsespray, suspension

orifarm a/s - mometasonfuroat monohydrat - næsespray, suspension - 50 mikrogram/dosis

Mometason "Orion" 50 mikrogram/dosis næsespray, suspension Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

mometason "orion" 50 mikrogram/dosis næsespray, suspension

orion corporation - mometasonfuroat monohydrat - næsespray, suspension - 50 mikrogram/dosis

Enerzair Breezhaler Den Europæiske Union - dansk - EMA (European Medicines Agency)

enerzair breezhaler

novartis europharm limited - indacaterol, glycopyrronium bromide, mometasone - astma - medicin for obstruktiv sygdomme, - enerzair breezhaler is indicated as a maintenance treatment of asthma in adult patients not adequately controlled with a maintenance combination of a long acting beta2 agonist and a high dose of an inhaled corticosteroid who experienced one or more asthma exacerbations in the previous year.

Bemrist Breezhaler Den Europæiske Union - dansk - EMA (European Medicines Agency)

bemrist breezhaler

novartis europharm limited  - indacaterol, mometasone furoate - astma - medicin for obstruktiv sygdomme, - bemrist breezhaler is indicated as a maintenance   treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.

Atectura Breezhaler Den Europæiske Union - dansk - EMA (European Medicines Agency)

atectura breezhaler

novartis europharm limited  - indacaterol acetate, mometasone furoate - astma - medicin for obstruktiv sygdomme, - atectura breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.

Zimbus Breezhaler Den Europæiske Union - dansk - EMA (European Medicines Agency)

zimbus breezhaler

novartis europharm limited - glycopyrronium bromide, indacaterol (acetate), mometasone furoate - astma - medicin for obstruktiv sygdomme, - maintenance treatment of asthma in adults whose disease is not adequately controlled.